Joseph Temming, MD
Rheumatology · Crestview Hills, KYNPI 1407851215
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.8% of the total across 73 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by AbbVie at 26.0% of the total. Reporting peaked in 2022 at $674 and has fallen 90.1% since, to $67 in 2025. That places this record below the midpoint for rheumatology clinicians in KY, where the typical reported total is $2,001.
Across 73 payments — averaging $23.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$438
- Novartis$365
- Amgen$325
- Johnson & Johnson$244
- UCB, Inc.$156
- E.r. Squibb & Sons, L.L.C.$41
- plus $116 from 5 others
What the payments were for
- Food & beverage$1,53191%
- Education$1559%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 20 | $438 |
| Novartis | 18 | $365 |
| Amgen(2 entities) | 16 | $325 |
| Johnson & Johnson(3 entities) | 7 | $244 |
| UCB, Inc. | 4 | $156 |
| E.r. Squibb & Sons, L.L.C. | 2 | $41 |
| Pfizer | 2 | $33 |
| Ultragenyx Pharmaceutical Inc. | 1 | $25 |
| AstraZeneca | 1 | $20 |
| ANI Pharmaceuticals, Inc. | 1 | $20 |
| Fresenius Kabi USA, LLC | 1 | $18 |
How this compares
$1,686 in reported general payments places this provider in the 45th percentile of 81 rheumatology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enbrel SureclickEtanercept | 34 | $238,410 |
| MethotrexateMethotrexate Sodium | 291 | $5,470 |
| Mycophenolate Mofetil | 25 | $3,260 |
| Hydroxychloroquine Sulfate | 88 | $2,599 |
| Tramadol Hcl | 265 | $1,695 |
| Prednisone | 181 | $1,608 |
| Allopurinol | 90 | $1,201 |
| Colchicine | 22 | $1,167 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 31 | $1,010 |
| Omeprazole | 74 | $791 |
| Celecoxib | 31 | $790 |
| Meloxicam | 88 | $492 |
| Diclofenac Sodium | 28 | $427 |
| Methylprednisolone | 58 | $420 |
| Folic Acid | 22 | $304 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Crestview Hills
- Liza VargheseCrestview Hills$29K
- Christopher ColglazierCrestview Hills$22K
- Kerrin BurteCrestview Hills$16K
- Abraham TacangCrestview Hills$9K
- Ann GeorgeCrestview Hills$8K
- Magdalena WiniarskaCrestview Hills$5K
- Mazen ElyanCrestview Hills$4K
- Sarah KellerCrestview Hills$3K
- Nicola JacksonCrestview Hills$2K
- Zehra KazmiCrestview Hills$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.